Metabolism and Metabolic Disorders and the Microbiome: The Intestinal Microbiota Associated With Obesity, Lipid Metabolism, and Metabolic Health—Pathophysiology and Therapeutic Strategies

Judith Aron-Wisnewsky*, Moritz V. Warmbrunn, Max Nieuwdorp, Karine Clément

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Abstract

Changes in the intestinal microbiome have been associated with obesity and type 2 diabetes, in epidemiological studies and studies of the effects of fecal transfer in germ-free mice. We review the mechanisms by which alterations in the intestinal microbiome contribute to development of metabolic diseases, and recent advances, such as the effects of the microbiome on lipid metabolism. Strategies have been developed to modify the intestinal microbiome and reverse metabolic alterations, which might be used as therapies. We discuss approaches that have shown effects in mouse models of obesity and metabolic disorders, and how these might be translated to humans to improve metabolic health.
Original languageEnglish
Pages (from-to)573-599
Number of pages27
JournalGastroenterology
Volume160
Issue number2
DOIs
Publication statusPublished - 1 Jan 2021

Cite this